Xeljanz, Rinvoq, Olumiant Labels To Warn Of Heart, Cancer, Death Risk
SILVER SPRING, Md. — The Food and Drug Administration on Sept. 2 announced that it is requiring revisions to the black box warnings for Xeljanz, Olumiant and Rinvoq due to the...To view the full article, register now.
Already a subscriber? Click here to view full article